combretastatin A4 analog (University of Arkansas for Medical Sciences)

N/A

Report date: 2025/01/26 19:11:34
NME

Base Information

Drug Namecombretastatin A4 analog (University of Arkansas for Medical Sciences)
Drug Alias NamePNR-5-02
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTubulin modulatorsGlial fibrillary acidic protein modulators
TargetsGlial fibrillary acidic proteinTubulin
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States Minor Outlying Islands
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Arkansas For Medical Sciences
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of Arkansas For Medical Sciences
Inactive CompaniesN/A
Active IndicationsAlzheimer Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A